Stocktoria
Cingulate Inc. CING
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2021-10-07
Chart by TradingView
1/9
Piotroski F — financial health
-36.57
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Operating income | -$19.9M | -$15.6M | -$22.8M | -$17.5M | -$20.7M |
| Net income | -$22.4M | -$16.6M | -$23.5M | -$17.7M | -$20.7M |
| Operating cash flow | -$17.2M | -$18.5M | -$15.0M | -$15.9M | -$10.4M |
| Free cash flow | -$17.4M | -$18.7M | -$15.3M | -$16.0M | -$11.2M |
| Total assets | $15.1M | $14.9M | $3.5M | $11.4M | $22.9M |
| Total liabilities | $12.6M | $7.4M | $10.4M | $7.5M | $2.0M |
| Shareholders' equity | $2.5M | $7.5M | -$6.9M | $3.9M | $20.8M |
| Ratios | |||||
| Return on assets | -148.9% | -111.4% | -674.1% | -155.0% | -90.5% |
| Return on equity | -894.8% | -222.1% | 342.6% | -455.3% | -99.4% |
| Current ratio | 1.16 | 2.55 | 0.06 | 1.12 | 16.05 |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 31,888 | $198,024 |
Why these scores methodology →
Piotroski F-score: 1/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -36.57 (distress)
- Working capital / assets 0.112
- Retained earnings / assets -8.782
- EBIT / assets -1.323
- Equity / liabilities 0.2
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001862150 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.